The Diagnosis and Treatment of Pouchitis in Inflammatory Bowel Disease

Journal of Clinical Gastroenterology

Volumn 38, Issue 5, 2004, Pages

  Cheifetz, Adam ^a,b   Itzkowitz, Steven ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Inflammatory bowel disease; Pouchitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL 3;

ALLELE; ANTIBIOTIC THERAPY; ANUS FISTULA; BACTERIAL OVERGROWTH; COLITIS; COLON ISCHEMIA; COLORECTAL SURGERY; CONFERENCE PAPER; CROHN DISEASE; DIAGNOSTIC ACCURACY; DYSPLASIA; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; GENETIC SUSCEPTIBILITY; GRANULOMATOUS INFLAMMATION; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM MUCOSA; ILEUM POUCH; MAINTENANCE THERAPY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; ULCERATIVE COLITIS;

EID: 2142647807     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000124001.93146.ef     Document Type: Conference Paper

References (47)

1. Langholz E, Munkholm P, Davidsen M. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444.
2. Pemberton JH, Kelly KA, Beart RW Jr, et al. Ileal pouch-anal anastomosis for chronic ulcerative colitis: long-term results. Ann Surg. 1987;206:504-513.
3. Kock NG, Darle N, Hulten L, et al. Ileostomy. Curr Probl Surg. 1977;14:1-52.
4. Parks AG, Nicholls RJ, Belliveau P. Proctocolectomy with ileal reservoir and anal anastomosis. Br J Surg. 1980;67:533-538.
5. Utsunomiya J, Iwama T, Imajo M, et al. Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum. 1980;23:459-466.
6. Stocchi L, Pemberton JH. Pouch and pouchitis. Gastroenterol Clin North Am. 2001;30:223-241.
7. Svaniger G, Nordgren S, Oresland T, et al. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol. 1993;28:695-700.
8. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long term outcome in 1310 patients. Br J Surg. 1998;85:800.
9. Ståhlberg D, Gulberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis: incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012-1018.
10. Dozois RR, Kelly KA, Welling DR, et al. Ileal pouch-anal anastomosis: comparison of results in familial adenomatous polyposis and chronic ulcerative colitis. Ann Surg. 1989;210:268.
11. Mahadevan U, Sandborn S. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636-1650.
12. Lohmuller JL, Pemberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg. 1990;211:622-627.
13. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-239.
14. Carter MJ, Di Giovine FS, Cox A, et al. The interleukin-1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology. 2001;121:805-811.
15. Merrett MN, Mortensen N, Kettlewell M, et al. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut. 1996;38:362-364.
16. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut. 2001;49:671-677.
17. Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis. Scand J Gastroenterol. 2000;35:1170-1173.
18. Moskowitz RL, Shephard NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis. 1986;1:167-174.
19. Di Febo G, Miglioli M, Lauri A, et al. Endoscopic assessment of acute inflammation of the ileal reservoir after restorative ileo-anal anastomosis. Gastrointest Endosc. 1990;36:6-9.
20. Shephard NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol. 1987;40:601-607.
21. Shepherd NA, Hulten L, Tytgat GNJ, et al. Pouchitis Workshop. Int J Colorectal Dis. 1989;4:205-229.
22. Warren BF, Sheppard NA. The role of pathology in pelvic ileal reservoir surgery. Int J Colorectal Dis. 1992;7:68-75.
23. Shepherd NA, Healy CJ, Warren BF, et al. Distribution of mucosal pathology and assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut. 1993;34:101-105.
24. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001;121:261-267.
25. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972-977.
26. Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum. 2001;44:487-499.
27. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clinic Proc. 1994;69:409-415.
28. Heuschen UA, Allemeyer EH, Hinz U, et al. Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum. 2002;45:776-786.
29. Shen B, Achkar JP, Connor JT, et al. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003;46:748-753.
30. Sandborn W. Pouchitis: Definition, Risk Factors, Frequency, Natural History, Classification, and Public Health Perspective. Dordrecht, the Netherlands: Kluwer Academic; 1997:51-63.
31. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497-500; discussion 501-502.
32. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301-305.
33. Schwartz D, Sandborn W. Chronic pouchitis. In: Bayless T, Hanauer S, eds. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, Ontario: Decker; 2001.
34. Madden MV, McIntyre AS, Nicholls RJ. Double-blind placebo crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci. 1994;39:1193.
35. Mimura T, Rizzello F, Helwig U, et al. Four-week open label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther. 2002;16:909-917.
36. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Phamacol Ther. 1999;13:713-718.
37. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double blind placebo controlled trial. Gastroenterology. 2000;119:305-309.
38. Mimura T, Rizello F, Schreiber S, et al. Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refractory pouchitis: a randomized, placebo-controlled, double-blind trial [Abstract]. Gastroenterology. 2002;122:A667.
39. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202-1209.
40. Kuzela L, Kascak M, Vavrecka A. Induction and maintenance of remission with nonpathogenic Escherichia coli in patients with pouchitis. Am J Gastroenterol. 2001;96:3218-3219.
41. Boschi S, Gionchetti P, Brignola C, et al. Evaluation of logistic pattern in pouchitis before and after the treatment with budesonide suppositories [Abstract]. Gastroenterology. 1992;102:A593.
42. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blind, double-dummy, controlled trial. Aliment Phamacol Ther. 2002;16:27-34.
43. Ricart E, Panaccione R, Loftus E, et al. Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology. 1999;117:429-432.
44. Joelsson M, Andersson M, Bark T, et al. Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis: a randomized placebo-controlled double-blind study. Scand J Gastroenterol. 2001;36:1179-1184.
45. Gullberg K, Stahlberg D, Liljeqvist L, et al. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology. 1997;112:1487-1492.
46. Thompson-Fawcett MW, Marcus V, Redston M, et al. Risk of dysplasia in Long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology. 2001;121:275-281.
47. O'Riordain MG, Fazio VW, Lavery IC, et al. Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up. Dis Colon Rectum. 2000;43:1660-1665.